10th Feb 2005 15:09
Sinclair Pharma PLC10 February 2005 Sinclair Pharma plc (the "Company") Application has been made to the London Stock Exchange for the admission of849,140 new ordinary shares of 1p each fully paid, ranking pari passu with theexisting ordinary shares ("Ordinary Shares"), to trading on the AlternativeInvestment Market ("AIM"). These new Ordinary Shares were allotted as part ofthe consideration for the acquisition of New Co Derm SRL (formerly EurodermR.D.C S.p.A), by the Company, which was announced on 21 December 2004. In addition, application has been made to the London Stock Exchange for theadmission of 20,000 new Ordinary Shares to trading on AIM. These new OrdinaryShares were allotted pursuant to the exercise of share options in accordancewith the Company's Unapproved Share Option Scheme. Trading in the 869,140 new Ordinary Shares is expected to commence on 11February 2005. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma